Investigation of the Timely-coordinated Therapy of Patients With Metastatic Cancer by Radiotherapy Together With Immune Checkpoint Inhibition
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Metastatic Cancer
- Type
- Observational
- Design
- Observational Model: Case-OnlyTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03453892
- Collaborators
- Not Provided
- Investigators
- Study Chair: Rainer Fietkau, Prof. Dr. Department of Radiation Oncology, Universitätsklinikum Erlangen Study Director: Markus Hecht, Dr. med. Department of Radiation Oncology, Universitätsklinikum Erlangen Study Director: Udo S Gaipl, Prof. Dr. Department of Radiation Oncology, Universitätsklinikum Erlangen